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Introduction: Transcutaneous electrical nerve stimulation (TENS) is a noninvasive, inex-
pensive, self-administered technique used throughout the world to relieve pain. In Sri Lanka, 
physiotherapists may use TENS for their patients as they receive a small amount of education 
about the principles and practice of TENS in their undergraduate training. To date, there have 
been no data gathered about the use of TENS by physiotherapists in Sri Lanka. The aim of this 
study was to assess attitudes and beliefs of physiotherapists working in Sri Lanka about their 
use of TENS for pain management.
Methods: A postal survey was undertaken using a 12-item questionnaire developed by the 
investigators to gather information about attitudes, beliefs and use of TENS in clinical practice. 
The questionnaire was distributed to 100 physiotherapists working in three government hospitals 
and six private hospitals in the cities of Kandy and Colombo. A descriptive analysis of data 
was performed.
Results: Sixty-seven completed questionnaires were returned (67% response rate). Over half of 
the respondents (58.2%) reported that they used TENS to treat pain “often” or “very often”, with 
use for musculoskeletal/orthopedic (61.3%) and neuropathic/neuralgic (79.1%) pain being most 
common. TENS was used less for postsurgical pain and rarely for cancer pain. Most (95.5%) respon-
dents reported that their patients benefitted “considerably” from TENS. 76.1% of the respondents 
reported that they did not  recommend and/or prescribe TENS for patients to use at home.
Conclusion: Physiotherapists value TENS as a treatment option to manage musculoskeletal 
and neuropathic pain. However, there is a need for systems and resources to enable to patients 
to self-administer TENS rather than having to visit clinics.
Keywords: transcutaneous electric nerve stimulation, electrotherapy, non pharmacological 
analgesia
Introduction
The use of electricity to manage human ailments is an age-old concept that dates back 
to 2500 BC when ancient Egyptians used electric fish to produce “shocks” to relieve 
pain.1 During the 19th century, the use of electricity in medicine gained popularity 
with the development of a variety of electromedical devices. From the mid-1960s, the 
pioneering works of Melzack and Wall,2 Shealy et al,3 Reynolds,4 and Long5 led to 
further developments in electroanalgesic techniques, resulting in the introduction of 
transcutaneous electrical nerve stimulation (TENS) into mainstream medicine.
TENS is a noninvasive, inexpensive, self-administered medical technique used 
throughout the world to relieve pain.6 The purpose of TENS is to excite  low-threshold 
peripheral afferent nerve fibers that convey neural information related to non-noxious 





stimuli to the brain, as this has been shown to close the “pain 
gate” and relieve pain.7 During TENS, pulsed currents of 
varying amplitude, duration, and frequency are generated 
by a portable battery-operated device and delivered via lead 
wires to electrodes attached to the intact surface of skin 
(Figure 1). The electrodes may be self-adhesive or smeared 
with conducting gel and secured using touch fastener straps 
or medical tape. The electrical characteristics of TENS 
can be adjusted by the user and dosage titrated according 
to need whenever the individual is experiencing pain. For 
most patients, pain relief during TENS is rapid in onset and 
associated with few adverse effects or drug interactions.6–8 
Systematic reviews and meta-analyses of randomized con-
trolled clinical trials provide evidence that TENS is effective 
for relief of many types of pain, including  musculoskeletal9 
and postsurgical pain.10 Some systematic reviews have failed 
to find efficacy11 or have been inconclusive.12 This has been 
attributed to methodological shortcomings in randomized 
controlled clinical trials, including the use of inappropriate 
TENS technique leading to underdosing.13,14 In general, it is 
believed that TENS should be used as a standalone treatment 
for mild-to-moderate pain and as an adjunct to pharmaco-
therapy for moderate-to-severe pain.7,8 TENS has also been 
used in the management of dementia,15 postoperative nausea 
and vomiting,16 and wound healing.17
A recent systematic review revealed that the prevalence 
of chronic pain worldwide is high – over 25%.18 There were 
insufficient reliable data by which to estimate with any 
certainty the prevalence of chronic pain in resource-limited 
countries with a Human Development Index (HDI) of less 
than 0.9, although prevalence appeared to be similar to that 
seen worldwide.18 The prevalence of chronic pain in Sri 
Lanka has not been established. Census data from 2012 found 
that the national population was 20,263,723 (http://www.
statistics.gov.lk/PopHouSat/CPH2012Visualization/htdocs/
index.php?usecase=indicator&action=Map&indId=10),19 
so approximately 5.08 million people may be  experiencing 
chronic pain at any one time if prevalence is taken as 25%. 
This burden of pain is likely to have a major impact on 
national health care costs.20–22 Pharmacotherapy remains 
the mainstay treatment for painful conditions in developing 
countries including Sri Lanka, although analgesic medication 
may cause significant adverse effects and access to opioid 
medication is a problem.23 The financial costs of pharma-
cotherapy can be high, especially if patients are prescribed 
analgesics for prolonged lengths of time.23 For these reasons, 
good practice guidelines for pain management recommend 
nonpharmacological alternatives as adjuncts for the manage-
ment of chronic pain.
In Sri Lanka, physicians, physiotherapists, nurses, and 
midwives may recommend the use of TENS to their patients. 
A TENS device and associated accessories are available with-
out prescription and can be bought at pharmacy outlets or via 
the internet for approximately 20,000 Sri Lankan rupees. All 
physiotherapists receive a small amount of education about 
the principles and practice of TENS in their undergraduate 
training or during clinical practice. To date, there have been 
no data gathered about the use of TENS by physiotherapists 
in Sri Lanka. Therefore, the aim of this postal survey was to 
assess attitudes and beliefs of physiotherapists working in Sri 
Lanka about their use of TENS for pain management.
Methods
The study was approved by the ethical review committee, 
 Faculty of Medicine, University of Peradeniya, Peradeniya, Sri 
Lanka. The postal survey was conducted throughout August and 
September 2012 on physiotherapists working in departments of 
physical medicine in government and private hospitals in two 
major Sri Lankan cities – Kandy and Colombo. At the time of 
the survey there were two government and two private hospitals 
with physiotherapy departments in Kandy, and two government 
and eleven private hospitals with physiotherapy departments 
in Colombo. Attempts were made to contact all physiotherapy 
departments to invite them to take part in the survey. Three 
government hospital departments (two in Kandy) and six private 
hospital departments (two in Kandy, four in Colombo) agreed to 
take part. The principal investigator (TDD) delivered, in person, 
a “survey pack” to each physiotherapy department.
The survey pack consisted of a participant information 
sheet, a formal invitation letter, and a survey  questionnaire, 
Figure 1 Tens device and accessories.
Abbreviation: Tens, transcutaneous electrical nerve stimulation.
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and was given to all members of the physiotherapy team who 
managed mixed caseloads of “pain patients”. The paper-based 
questionnaire consisted of 12 items and was designed by two 
members of the investigating team (GB, MIJ) and previously 
used on a population of Indian physiotherapists working in 
city hospitals in India.24 The questionnaire gathered informa-
tion about the attitudes and beliefs of physiotherapists about 
their use of TENS and its role in pain management.
After 1 month, completed questionnaires were collected 
by departmental chief physiotherapists and sent via post 
to the principal investigator. Questionnaires were coded to 
maintain anonymity, although the location of the physio-
therapy department was documented. A descriptive analysis 
was performed with data presented as counts and percentage 
responses to each question. It was decided not to conduct 
inferential statistics because of the relatively small sample 
size. SPSS v 17 (SPSS Inc., Chicago, IL, USA) was used to 
manage data and conduct the analysis.
Results
One hundred physiotherapists were given survey packs, 
and 67 completed questionnaires were returned (67% 
response rate). Sixty of the 67 (89.5%) respondents were 
registered physiotherapists, with seven of the 67 (10.4%) 
 respondents having their registration under renewal or pend-
ing (question [Q]12).
Of these 67 respondents, 64 (95.5%) reported that they 
treated pain “very often” (n=31) or “often” (n=33) in their 
clinical practice (Q1). Three respondents reported that they 
treated pain “occasionally”. Thirty-nine (58.2%) of these 
respondents reported that they used TENS to treat pain 
“often” (n=32) or “very often” (n=7) (Q2). Twenty-seven 
(40.3%) respondents reported that they used TENS to treat 
pain “occasionally” and one respondent reported that they 
used TENS “seldom”.
For the management of acute pain, 55.2% of  respondents 
reported that they used TENS “often” or “very often”, 
and 25.4% reported that they did not use TENS “at all” 
(Table 1 [Q3a]). For the management of subacute pain, 
61.2% of respondents reported that they used TENS “often” 
or “very often”, and only 6.0% reported that they did not use 
TENS “at all”. For the management of chronic pain, 55.2% 
of respondents reported that they used TENS “often” or 
“very often”, and the percentage of respondents reporting 
not “at all” was zero.
Only 65 respondents provided answers for questions 
related to the severity of pain (Q3b). A larger proportion 
of respondents reported that they used TENS “very often” 
or “often” for pains that were more severe. For example, 
23.1% of respondents reported that they used TENS “very 
often” or “often” for the management of mild pain, compared 
with 70.8% for the management of severe pain (Table 1). 
Only 12.3% of respondents reported that they did not use 
TENS “at all” for severe pain, compared with 29.2% for 
mild pain.
Respondents reported that they used TENS “very 
often” or “often” for pain associated with musculoskeletal/ 
orthopedics conditions (61.3%) or neuropathies/neural-
Table 1 Responses to questions related to types and severity of pain
Pain types/conditions Respondents per response, n (%)
Very often Often Occasionally Seldom Not at all
Q3a: For which types of pain do you use Tens?
• acute 16 (23.9) 21 (31.3) 2 (3.0) 11 (16.4) 17 (25.4)
•  subacute 6 (8.95) 35 (52.2) 14 (20.9) 8 (11.9) 4 (6.0)
•  chronic 9 (13.4) 28 (41.8) 29 (43.3) 1 (1.5) 0 (0)
Q3b: For which types of pain do you use Tens?
•  Mild 6 (9.2) 9 (13.85) 23 (35.4) 8 (12.3) 19 (29.2)
•  Mild to moderate 8 (12.3) 8 (12.3) 25 (38.5) 19 (29.2) 5 (7.7)
•  Moderate 0 (0) 24 (36.9) 23 (35.4) 12 (18.5) 6 (9.2)
•  Moderate to severe 10 (15.4) 27 (41.5) 22 (33.85) 0 (0) 6 (9.2)
•  severe 17 (26.15) 29 (44.6) 11 (16.9) 0 (0) 8 (12.3)
Q4: For which conditions do you commonly use Tens?
•  Musculoskeletal/orthopedic 21 (31.3) 20 (29.85) 15 (22.4) 4 (6.0) 7 (10.45)
•  neuropathy/neuralgia 16 (23.9) 37 (55.2) 7 (10.45) 3 (4.5) 4 (6.0)
•  Postsurgical 8 (11.9) 6 (8.95) 26 (38.8) 16 (23.9) 11 (16.4)
•  cancer pain 0 (0) 1 (1.5) 4 (6.0) 15 (22.4) 47 (70.1)
•  Other pains (eg, dysmenorrhea) 0 (0) 0 (0) 10 (14.9) 22 (32.8) 35 (52.2)
Note: There were 67 respondents for all questions except Q3b, for which there were 65 respondents.
Abbreviation: Tens, transcutaneous electrical nerve stimulation.





gias (79.1%) (Table 1 [Q4]). Only 10.45% and 6.0% of 
respondents reported that they did not use TENS “at all” for 
musculoskeletal/orthopedic or neuropathic/neuralgia pain 
respectively. Fewer respondents reported that they used TENS 
“very often” or “often” for pain associated with postsurgi-
cal conditions (20.9%) or cancer pain (1.5%). Forty-seven 
(70.1%) respondents reported that they that they did not use 
TENS “at all” for pain associated with cancer.
Sixty-four (95.5%) respondents reported that their 
patients benefitted “considerably” from TENS, with two 
respondents reporting “No improvement noticed” (Q5). 
Fifty-one respondents (76.1%) reported that they did not 
recommend/prescribe TENS for patients to use at home, sug-
gesting that patients needed to make clinic visits to receive 
TENS treatment (Figure 2 [Q6]).
Twenty-seven (40.3%) respondents reported that refer-
ring physicians had “never” recommended that the physio-
therapist use TENS for pain relief (Figure 3 [Q7]), and 47.7% 
of respondents reported that their patients had requested 
TENS treatment from them (Q8).
Twenty-five respondents (37.3%) reported that their 
patients had used TENS before they came to receive pain 
treatment (Q9), and 44.8% of respondents reported that they 
believed that TENS was a cost-effective treatment option 
(Figure 4 [Q10]). Sixty-two respondents (92.5%) reported 
that they also used TENS-like devices, including interferen-
tial therapy, to manage pain (Q11).
Discussion
This questionnaire survey of physiotherapists in two major 
cities in Sri Lanka found that 58.2% of respondents reported 
that they used TENS to treat pain “very often” or “often”, 
although over 95% reported that they believed that TENS 
was “considerably” beneficial. It was found that respondents 
reported that they often used TENS for neurological and 
musculoskeletal pain, but only “occasionally” for postsur-
gical pain and “seldom” for cancer pain. This pattern of 
use is similar to that seen in Australia, Europe, and USA, 
and is likely to reflect patient presentation patterns and 
beliefs of therapists about effectiveness of TENS for these 
conditions.8,25,26 Evidence from systematic reviews suggests 
that TENS is effective for chronic musculoskeletal pain,9 
neuropathic pains,26,27 and postsurgical pain.10,28 Evidence for 
effectiveness for cancer pain is limited but promising.29
A main finding of the survey was that over 76.1% of 
respondents reported that they did not recommend that TENS 
should be used at home. Thus, patients would need to visit the 
clinic in order for each TENS treatment session. This is costly 
in staff time and inconvenient for the patient. More importantly, 
however, infrequent and short-duration TENS treatment is not 
optimal clinical practice. In most circumstances, it is recom-
mended that TENS should be administered over the painful 
area or over peripheral nerves innervating the painful area. 
Yes, quite often, n=26
(38.8%)
Yes, but not very 
often, n=14 (20.9%)
Never, n=27 (40.3%)
Figure 3 Responses to Q7: “Does your referring physician advise you to use Tens 
for pain relief?”.
Abbreviation: Tens, transcutaneous electrical nerve stimulation.
Yes, n=30 (44.8%)
No, n=37 (55.2%)
Don’t know, n=0 (0%)
Figure 4 Responses to Q10: “Do you think Tens treatment is cost-effective 
compared with other treatments?”.





Figure 2 Responses to Q6: “Do you recommend/prescribe Tens to patients in 
pain at home?”.
Abbreviation: Tens, transcutaneous electrical nerve stimulation.
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Evidence suggests that a strong, non-painful TENS sensation 
is a prerequisite for success and that maximal pain relief occurs 
during stimulation.30 Therefore, successful long-term users of 
TENS self-administer TENS treatment regularly throughout 
the day because pain may return within minutes once TENS 
has stopped.31 Unfortunately, the questionnaire did not include 
an item to gather information about why physiotherapists did 
not recommend that patients should self-administer TENS at 
home. One reason for this may be inappropriate beliefs about 
how best to administer TENS, perhaps resulting from inad-
equate undergraduate training. The small amount of training 
given on TENS and other electrotherapies in undergraduate 
training may contribute to the development of inappropriate 
beliefs about how best to administer treatment. Inappropriate 
beliefs that all electrotherapy treatments have to be supervised 
by a health care professional has been highlighted for interfer-
ential current therapy.32,33 Evidence suggests that patients can 
safely administer TENS themselves providing they are trained 
on safe and appropriate technique by a competent health care 
professional.31 Training protocols are readily available.34
Another reason why respondents did not recommend 
that TENS should be used at home may be that patients 
(and clinics) are unable to afford to purchase their own 
TENS device, including ongoing costs of replacing bat-
teries and electrodes. This may account for the finding 
that only 44% of respondents reported that they believed 
that TENS was a cost-effective modality. One strategy to 
overcome this challenge is for patients to purchase or rent a 
TENS device from clinics or manufacturers at a subsidized 
cost with the proviso that the device is returned when it is no 
longer needed. This is an advantage of TENS when compared 
with drug medication, as the TENS device can be reused and 
recycled for use by other patients once it is no longer needed. 
The ability to finance the purchase of a sufficient stock of TENS 
devices to loan to patients may be a challenge for many clinics. 
Negotiating discounts for bulk purchase from manufacturers 
and charity fundraising activities can be used to reduce costs to 
the clinic.  Furthermore, TENS equipment is considerably more 
expensive in Sri Lanka costing approximately 20000 Sri Lankan 
Rupees,  equivalent to 9245 Indian Rupees. Indian-made TENS 
devices are available for approximately 2000 Indian Rupees, 
equivalent to 4330 Sri Lankan Rupees. Importing cheaper, 
Indian-made TENS devices in bulk may be a solution. Dete-
rioration of electrodes due to dusty environments resulting in 
the need for more frequent replacement of electrodes may also 
increase running costs.
Sociocultural acceptance of TENS as a viable treatment 
option may also be a potential barrier to widespread use, 
including difficulties in securing the TENS device to clothes 
because of the absence of a belt, for example, for women who 
wear “sarees”.  Nevertheless, the finding that nearly half of 
respondents reported that their patients had requested TENS 
treatment suggests that individuals with pain attending phys-
iotherapy clinics are aware of TENS, despite limited advertise-
ment of TENS through mainstream media.
Sri Lanka faces considerable challenges in delivering con-
sistent and quality health care services across the nation.21,22 
Pain management has been described as a fundamental human 
right that should be available in primary care settings,34,36 
yet pain management services in Sri Lanka are not given 
priority.35,36 Most pain management services are confined 
to large hospitals, often in the private sector, and located 
in major cities such as Colombo and Kandy. Provision in 
public or government hospitals appears to be inadequate.22 
This restricts pain management to people who can afford to 
pay for expensive treatments. TENS may be a cost-effective 
option for managing pain because it is a safe, inexpensive, 
and effective treatment that can be self-administered by the 
patient as needed and without fear of toxicity or overdose.
There were some methodological limitations to this 
study. The survey sample size was small and restricted to 
urban centers. Secondary health care services such as phys-
iotherapy are scantily resourced in rural Sri Lanka, so we 
suspect that TENS may be used less often in rural areas. The 
views of the 33% of physiotherapists that did not respond 
to the questionnaire are not known, and it is possible that 
these non-respondents did not use TENS or had used TENS 
previously and found it to be ineffective. For these reasons, 
we express caution in generalizing the findings to the wider 
physiotherapy population in Sri Lanka and we plan to conduct 
a larger in-depth survey of all health professionals engaged 
with TENS in rural as well as urban Sri Lankan areas.
Conclusion
Physiotherapists working in hospitals located in cities in Sri 
Lanka value TENS as a treatment option to manage muscu-
loskeletal and neuropathic pain. They were less likely to use 
TENS for mild pain and for cancer pain. There appears to be 
a need for systems and resources to enable patients to self-
administer TENS rather than having to visit clinics.
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